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Abstract: Transthyretin (TTR) accounts for a quarter of the protein content of ventricular 
cerebrospinal ﬂ  uid (CSF) yet its exact role in the brain remains unknown. Patients with a 
diagnosis of depression have reduced CSF levels of TTR and the locus encoding the TTR gene 
has been implicated in a Danish pedigree of bipolar patients. Lithium, the major treatment for 
bipolar disorder in the UK, was subcutaneously infused into rats for 28 days in the form of lithium 
chloride using osmotic minipumps. In situ hybridizations using oligonucleotide probes targeted 
against the TTR transcript were performed on coronal brain sections. Lithium signiﬁ  cantly 
reduced the level of transthyretin mRNA in the rat choroid plexus within the lateral and third 
ventricle. The down-regulation was conﬁ  rmed using semi-quantitative reverse transcription 
PCR on dissected brain tissue. Recent studies in mice suggest that the TTR gene is implicated 
in depression-like behavior therefore this effect of lithium may be relevant to its use as a mood 
stabilizer or an adjuvant to antidepressant drugs.
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Introduction
Transthyretin (TTR) is a 55-kDa tetrameric protein that is synthesized both in the liver 
and in the choroid plexus of the brain and secreted into the plasma and cerebrospinal 
ﬂ  uid (CSF) respectively. Although TTR can bind both thyroxin and retinol (via retinol 
binding protein) in the plasma, its precise role in the CNS has yet to be established. 
The regulation of TTR synthesis and secretion from the choroid plexus is independent 
from that in the liver (Dickson et al 1986) and it does not appear to be involved in the 
distribution of thyroid hormones throughout the brain, at least not in rodents (Blay 
et al 1993; Palha et al 2000). TTR has been implicated in both Alzheimer’s disease 
(Riisoen 1988) and affective disorder (Sullivan et al 1999) as patients suffering 
from these disorders show reduced levels of TTR in their CSF compared to controls. 
A recent behavioral study also suggests that TTR-null mice demonstrate behaviors 
consistent with those of subjects which have been administered antidepressants in 
some preclinical screens (Sousa et al 2004).
Evidence that TTR is implicated in the pathophysiology of bipolar disorder 
comes from a genetic study that demonstrated positive LOD scores for markers on 
Chromosome 18q12 (the same region as the TTR locus) with a Danish pedigree of 
BD patients (Ewald et al 1997). Lithium is the major treatment for bipolar disorder in 
the UK but the neural mechanisms underlying its therapeutic efﬁ  cacy are not known. 
One of the effects lithium has at the molecular level is to modulate AP-1 binding to 
DNA (reviewed (Ikonomov et al 1999)) and the TTR promoter has been shown to 
contain a functional AP-1 binding site (Qian et al 1995). To investigate if in vivo 
lithium administration regulated brain TTR expression we examined the effects of 
28 days continuous infusion in the rat.Neuropsychiatric Disease and Treatment 2006:2(4) 550
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Methods
Subjects and treatment
Experiments were conducted in accordance with the UK 
Animals (Scientiﬁ  c Procedures) Act 1986. Male Lister 
hooded rats (257 ± 3 g) were obtained from Harlan UK 
and housed in pairs in polycarbonate cages kept within a 
temperature-controlled room (21°C) on a 12-h light-dark 
cycle (lights on at 6 am). Food and water were available 
ad lib. Rats were anesthetized using halothane (5% for 
induction and 2% maintenance) and osmotic minipumps 
(Alzet) were implanted subcutaneously through a skin 
incision made at the level of the shoulder. Minipumps were 
preloaded with either vehicle (n = 6) or lithium chloride 
dissolved in sterile water (n = 6) at a concentration designed 
to provide a constant infusion of 75 mg/kg/day. A solution 
of  NaCl was offered in water bottles as a precaution against 
lithium toxicity.
Twenty-eight days following minipump implantation 
the rats were killed and the brains removed and frozen in 
isopentane (–35°C). The mean plasma lithium concentration, 
measured using flame emission spectrophotometry 
(Instrument Laboratory Model 943), was 0.35 ± 0.04 mmol/L. 
Brains were stored at –80°C before being sectioned coronally 
(20 μm) between 4.7 mm anterior and 3.8 mm posterior to 
Bregma on a cryostat. Sections were thaw-mounted onto 
superfrost slides (BDH) and stored at –80°C for no more 
than 2 weeks prior to further processing.
In-situ hybridization
A synthetic oligonucleotide probe designed to spe-
cifically target rat mRNA for TTR was synthesized 
by Invitrogen (UK). Probes sequence: TTR, bases 
38–82 (5’- AGCGAGGCAGAGGAGGAACAGGC-
GAAGGGAAGCCATCCTGTCAGG-3’). Probes for two 
housekeeping genes β-actin and glyceraldehyde-3-phos-
phate dehydrogenase (G3PDH) were synthesized by Life 
Technologies (GIBCO, BRL). Probe sequences: β-actin, 
bases 251–295 (5'- TGGACCGGGACGGAGGAGCTG-
CAAGGAGGTTGTACTCGCGGGTGG-3') and G3PDH, 
bases 698–737 (5'-CACGGAAGGCCATGCCAGT-
GAGCTTCCCGT-3'). Oligonucleotides were labeled with 
33P-dATP (3000 Ci/mmol) by tailing the 3'-end using ter-
minal transferase (Promega) as described previously (Henry 
et al 1999). Probes were puriﬁ  ed using Micro Bio-Spin chro-
matography columns (P-30 Tris RNase-free, Bio-Rad).
Sections were prepared, incubated with labeled probes 
for 18 hours at 42°C and washed as previously described 
(Henry et al 1999). After dehydration, the slides were 
placed in a cassette and exposed to X-ray ﬁ  lm (BioMax 
MR-1, Kodak) and then developed using a Kodak automatic 
developer (M-35M X-OMAT Processor). Following devel-
opment of autoradiographs, all slides were counter-stained 
with Haematoxylin and Eosin (H&E, DAKO). Analysis 
of H&E-stained sections indicated no overt deterioration 
in section quality or morphology. Densitometric analysis 
of autoradiographs was performed using a Microcomputer 
Imaging Device (MCID) system (Imaging Research Inc.). At 
a 2-hour exposure time the measured optical density remained 
on the linear part of the ﬁ  lm response and was chosen for 
further analysis.
Optical density measurements were obtained for the lateral 
ventricles by taking 2 readings (left and right) from 3 sections 
at each of 4 regions of interest (level 5: AP + 0.2 mm, Level 6: 
AP –2.2 mm, Level 7: AP –2.8 mm and Level 8: AP –3.8 mm) 
for each rat. For the third ventricle a single reading was taken 
from 3 sections at 3 regions of interest (Level 6, 7, and 8) 
for each rat. The mean value for each level was calculated 
after background subtraction for all subjects. The data were 
analyzed using analysis of variance for repeated measures 
(ANOVAR) with GROUP as the between subject factor and 
LEVEL as the within subject factor.
Semi-quantitative (SQ)-RT-PCR
The hippocampus together with associated choroid plexus 
(Puskas et al 2003) was removed from another set of rats 
treated with lithium (n = 3) or vehicle (n = 3) in an identical 
manner. Total RNA was isolated from each before being 
pooled into single control and treated samples that were 
treated to remove contaminating DNA. 1 μg from each 
pool was reverse transcribed in the presence of 20 pmol 
oligo(dT)18 primer in a ﬁ  nal reaction volume of 20 μL. 
After incubation at 42oC for 1 hour the enzyme was heat-
inactivated and resulting cDNA was diluted to 10 ng/μL 
and integrity checked by PCR using β-actin or TTR gene 
primer pairs. Each 50 μl PCR reaction contained; 10 ng 
cDNA, 10 mM Tris-HCl, pH 8.3, 50 mM KCl, 1.5 mM 
MgCl2, 200 μM each dNTP, 100 ng each primer, and 2.5 U 
AmpliTaq Gold. Reactions were initiated for 10 min at 95oC 
and then continued with 35 cycles at; 94oC for 1 min, 45oC 
for 1 min and 72oC for 2 min. Cycle number optimization 
was performed with 10 ng cDNA per reaction and was 
determined by graphical means by plotting cycle number, 
in 2 cycle increments ranging from 18 to 30 cycles, against 
total counts per PCR product. The optimal number of cycles 
was determined to be when the accumulation of product was 
linear in a dilution series. Following optimization (data not Neuropsychiatric Disease and Treatment 2006:2(4) 551
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shown) radioactive SQ-RT-PCR was carried out by addition 
of 0.5 μCi [α-33P]dATP per reaction. Products were run on 
6% non-denaturing acrylamide-TBE gels (Novex). Total 
counts of radioactivity per band were recorded on the Storm 
840 phosphorimager and subject to imageQuant analysis. 
Counts for TTR from control and treated samples were 
normalized to respective β-actin counts at each dilution and 
the values obtained from the treated sample were recorded 
as a percentage of control levels.
Results
In-situ hybridization
The TTR signal was conﬁ  ned to the lateral and third ventricles 
in areas of the brain that contain choroid plexus: (Figure 1A, D) 
consistent with previous studies (Herbert et al 1986; Stauder 
et al 1986). Treatment with lithium chloride reduced the 
mean optical density in both the lateral (Figure 2A) and 
third (Figure 2B) ventricles. There were signiﬁ  cant effects of 
GROUP for both the lateral (F1,10= 5.8, p   0.05) and third 
C F
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Figure 1 Autoradiographs of coronal sections (AP –2.8 mm) from a typical vehicle-treated (panel A-C) or lithium-treated (panel D-F) animal hybridized with 3’ end 
33P-labelled oligoprobes to TTR (A, D), glyceraldehyde-3-phosphate dehydrogenase (B,E), and β-actin (C,F) mRNA. Note that the TTR signal (indicated by arrows) is 
restricted to the choroid plexus of the 3rd ventricle (3rdV) and lateral ventricle (LV) and is weaker in the lithium-treated brain. The signal distribution for the house-keeping 
genes G3PDH or β-actin from adjacent sections was similar to that previously described and did not differ between the groups.Neuropsychiatric Disease and Treatment 2006:2(4) 552
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ventricle (F1,10= 5.2, p   0.05) analyses conﬁ  rming that lithium 
signiﬁ  cantly reduced TTR expression. There were also signiﬁ  -
cant effects of LEVEL in the expression of TTR for both lateral 
(F3,30= 18.7, p   0.001) and third (F2,20= 5.2, p   0.05) ventricles 
but no signiﬁ  cant GROUP by LEVEL interactions suggesting 
that although there was signiﬁ  cant variation in the expression 
of TTR rostrocaudally throughout the ventricular system, the 
decrease in TTR gene expression following lithium treatment 
occurred consistently across the regions of interest.
Optical density readings for oligonucleotide probes 
targeted against the housekeeping genes β-actin (Figure 1B 
and E) or G3PDH (Fig 1C and F) obtained from the lateral 
and third ventricle of adjacent sections showed similar levels 
of expression in lithium-treated and vehicle treated groups 
(Table 1). Statistical analysis (ANOVA) confirmed no 
signiﬁ  cant differences between the two groups in the overall 
levels of expression of either β-actin (p   0.5) or G3PDH 
(p   0.1).
Semi-quantitative (SQ)-RT-PCR
The expression of β-actin did not appear to change 
between control and lithium treated tissue whereas TTR 
expression appeared reduced at all dilutions (Figure 3). 
The normalized expression of TTR in tissue from vehicle 
treated rats was 799.3 and from lithium-treated tissue 
was 49.8. Relative expression of TTR following lithium 
treatment was therefore reduced by 94% compared with 
vehicle.
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Figure 2 Effect of lithium treatment on TTR mRNA expression throughout the brain. Semi-quantitative densitometric analysis revealed a signiﬁ  cant decrease in optical 
density in both the lateral ventricle (A) and the third ventricle (B) in rats treated with lithium chloride (n = 6) compared with vehicle (n = 6) at each level. Data represent 
mean of 6 optical density readings for lateral ventricle and 3 optical density readings for third ventricle ± SEM.Neuropsychiatric Disease and Treatment 2006:2(4) 553
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Discussion
Twenty-eight days of lithium treatment signiﬁ  cantly down 
regulated TTR mRNA expression in the rat. In-situ hybrid-
ization demonstrated an average 25% decrease in TTR 
mRNA expression in the choroid plexus from rats treated 
chronically with lithium when compared to vehicle treated 
animals. Conﬁ  rmation that mRNA for house-keeping genes 
was not signiﬁ  cantly affected by treatment demonstrated 
that the decrease in TTR mRNA expression was not due 
to a non-speciﬁ  c loss of tissue in the lithium treated brain 
sections. The effect of lithium was conﬁ  rmed in dissected 
brain tissue containing both hippocampus and choroid plexus 
using SQ-RT-PCR with a 94% decrease in TTR mRNA in 
the pooled treated sample. While there is no clear explanation 
why SQ-RT-PCR detected a larger down-regulation of TTR 
mRNA expression, it is not unusual to observe discrepancies 
between absolute levels of mRNA detected using different 
experimental techniques (Riesewijk et al 2003). Importantly 
SQ-RT-PCR conﬁ  rmed the same direction of altered TTR 
mRNA expression following 28 days of treatment with 
lithium chloride.
The present study did not investigate whether decreased 
TTR mRNA expression resulted in a reduced level of 
protein in the CSF. A previous study found that a dose of 
nicotine that produced an increase of approximately 60% in 
TTR mRNA expression measured using SQ-RT-PCR also 
signiﬁ  cantly increased TTR protein levels in the CSF by 
∼12% (Li et al 2000).
It is unclear exactly what the consequences of a reduction 
in TTR levels might be for neurotransmission within 
the CNS. Neurochemical measures from the TTR-null 
mouse suggest that a lifetime absence produces an increase 
in the levels of norepinephrine in the limbic forebrain 
(Sousa et al 2004). A more recent study has also demon-
strated increased levels of the amidated neuropeptide trans-
mitters neuropeptide Y and substance P as a consequence 
of overexpression of peptidylglycine α-amidating mono-
oxygenase (Nunes et al 2006) in TTR-null mice. TTR has 
been shown also to sequester the protein beta-amyloid 
(Aβ), the major component of the senile plaques found 
in Alzheimer brains, and prevent its aggregation in vitro 
(Schwarzman et al 1994). In addition, selective antibody 
blockade of TTR in a mutant mouse that over-expresses the 
amyloid precursor protein (APPSW) leads to increased Aβ 
deposition and cell death (Stein et al 2004). Previous stud-
ies have shown that ginkgo biloba (Watanabe et al 2001), 
Vehicle Lithium
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Figure 3 Semi-quantitative-RT-PCR from lithium (n = 3) and vehicle-treated rats (n = 3). Expression levels were studied using oligonucleotides directed towards TTR: primers 
5’- AAT ACG CAG AGG TGG TTT TC-3’ and 5’-GGC ATC TTC CCG AGT TG-3’ and to β-actin: primers 5’-TTG TAA CCA ACT GGG ACG ATA TGG-3’ and 5’-GAT CTT 
GAT CTT CAT GGT GCT AGG-3’. Shown is an example of the accumulation of product with 30 cycles of PCR for a serial dilution of template cDNA ranging from; lane 
1 = 10 ng, 2 = 5 ng, 3 = 2.5 ng, 4 = 1.25 ng and 5 = 0.625 ng. Product sizes are indicated relative to 1 kb DNA markers (M).
Table 1 Expression of mRNA for house-keeping genes in the choroid plexus region of the ventricles following infusion of vehicle or 
lithium chloride for 28 days
β-actin G3PDH
Lat ventricle 3rd ventricle Lat ventricle 3rd ventricle
Vehicle(n = 6) 0.143 ± 0.005 0.136 ± 0.008 0.082 ± 0.019 0.077 ± 0.026
Lithium(n = 6) 0.141 ± 0.004 0.130 ± 0.005 0.072 ± 0.006 0.063 ± 0.012
Notes: Sections adjacent to those used for TTR mRNA expression (level 7) were hybridized with labeled probes for β-actin or G3PDH. For the lateral ventricle the mean 
value (±SE) was calculated from 2 optical density readings (left and right) in 3 sections and for the third ventricle from a single reading in 3 sections.Neuropsychiatric Disease and Treatment 2006:2(4) 554
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omega 3 fatty acids (Puskas et al 2003), nicotine (Li et al 
2000) or estradiol (Tang et al 2004) produce increased 
TTR mRNA expression and this was considered to be a 
beneﬁ  cial effect. Although we have shown that lithium 
down-regulates TTR, it may also reduce Aβ levels by 
inhibiting its production both in vitro and in transgenic 
mice (Su et al 2004).
With regard to the role of lithium in affective disorder, 
the lithium-induced reduction in the levels of TTR mRNA 
may be consistent with observation that TTR-null mice 
behave in a manner similar to mice given antidepres-
sants prior to the forced swim test (Sousa et al 2004). 
This may or may not be mediated through neuropeptide 
Y which is increased in both TTR-null mice (Nunes et al 
2005) and following chronic lithium administration in 
rats (Zachrisson et al 1995). Central administration of 
NPY also demonstrates antidepressant activity when 
administered centrally (Redrobe et al 2002). On the other 
hand, TTR protein levels in the CSF of some depressed 
patients have been found to be reduced (Sullivan et al 
1999), suggesting that there may be no simple relationship 
between TTR function and mood state. Although lithium 
is used clinically to augment antidepressant drug therapy 
(Fawcett 2003) its primary indication is as a mood stabilizer 
or anti-manic agent in bipolar disorder. In the absence of 
a useful animal model of bipolar disorder, further studies 
with additional mood stabilizing agents such as carbam-
azepine or sodium valproate may help to determine if a 
decrease in TTR is speciﬁ  c to lithium or whether it has 
signiﬁ  cance with regard to the clinical efﬁ  cacy of mood 
stabilizers in general.
Note: Nucleotide sequence data reported are annotated in the 
GenBank and NCBI databases: TTR (gi:205981, K03252); 
b-actin (gi: 55574, V01217); G3PDH (gi: 31377487, 
NM 017008).
Acknowledgments
This research was generously supported by Organon Labora-
tories Ltd. The authors would like to thank Mark Anderson 
at Organon for preparation of rat brains and Nik Harries for 
carrying out SQ-RT-PCR.
References
Blay P, Nilsson C, Owman C, et al. 1993. Transthyretin expression in the rat 
brain: effect of thyroid functional state and role in thyroxine transport. 
Brain Res, 632:114–20.
Dickson PW, Aldred AR, Marley PD, et al. 1986. Rat Choroid-Plexus 
Specializes in the Synthesis and the Secretion of Transthyretin 
(Prealbumin) - Regulation of Transthyretin Synthesis in Choroid-Plexus 
Is Independent from That in Liver. J Biol Chem, 261:3475–8.
Ewald H, Mors O, Koed K, et al. 1997. Susceptibility loci for bipolar 
affective disorder on chromosome 18? A review and a study of Danish 
families. Psychiatr Genet, 7:1–12.
Fawcett JA. 2003. Lithium combinations in acute and maintenance treatment 
of unipolar and bipolar depression. J Clin Psychiatry, 64(Suppl 5):
32–7.
Henry B, Crossman AR, Brotchie JM. 1999. Effect of repeated 
L-DOPA, bromocriptine, or lisuride administration on 
preproenkephalin-A and preproenkephalin-B mRNA levels in 
the striatum of the 6-hydroxydopamine-lesioned rat. Exp Neurol, 
155:204–20.
Herbert J, Wilcox JN, Pham KT, et al. 1986. Transthyretin: a choroid plexus-
speciﬁ  c transport protein in human brain. The 1986 S. Weir Mitchell 
award. Neurology, 36:900–11.
Ikonomov OC, Manji HK. 1999. Molecular mechanisms underlying mood 
stabilization in manic-depressive illness: the phenotype challenge. Am 
J Psychiatry, 156:1506–14.
Li MD, Kane JK, Matta SG, et al. 2000. Nicotine enhances the 
biosynthesis and secretion of transthyretin from the choroid plexus 
in rats: implications for beta-amyloid formation. J Neurosci, 
20:1318–23.
Nunes AF, Saraiva MJ, Sousa MM. 2006. Transthyretin knockouts 
are a new mouse model for increased neuropeptide Y. Faseb 
Journal, 19.
Palha JA, Fernandes R, de Escobar GM, et al. 2000. Transthyretin regulates 
thyroid hormone levels in the choroid plexus, but not in the brain 
parenchyma: study in a transthyretin-null mouse model. Endocrinology, 
141:3267–72.
Puskas LG, Kitajka K, Nyakas C, et al. 2003. Short-term administration 
of omega 3 fatty acids from ﬁ  sh oil results in increased transthyretin 
transcription in old rat hippocampus. Proc Natl Acad Sci U S A, 
100:1580–5.
Qian X, Samadani U, Porcella A, et al. 1995. Decreased expression 
of hepatocyte nuclear factor 3 alpha during the acute-phase 
response inﬂ  uences transthyretin gene transcription. Mol Cell Biol, 
15:1364–76.
Redrobe JP, Dumont Y, Fournier A, et al. 2002. The neuropeptide Y (NPY) 
Y1 receptor subtype mediates NPY-induced antidepressant-like activity 
in the mouse forced swimming test. Neuropsychopharmacology, 
26:615–24.
Riesewijk A, Martin J, van Os R, et al. 2003. Gene expression pro-
filing of human endometrial receptivity on days LH+2 versus 
LH+7 by microarray technology. Mol Hum Reprod, 9:253–64.
Riisoen H. 1988. Reduced prealbumin (transthyretin) in CSF of severely 
demented patients with Alzheimer’s disease. Acta Neurol Scand, 
78:455–9.
Schwarzman AL, Gregori L, Vitek MP, et al. 1994. Transthyretin sequesters 
amyloid beta protein and prevents amyloid formation. Proc Natl Acad 
Sci U S A, 91:8368–72.
Sullivan GM, Hatterer JA, Herbert J, et al. 1999. Low levels of 
transthyretin in the CSF of depressed patients. Am J Psychiatry, 
156:710–15.
Sousa JC, Grandela C, Fernandez-Ruiz J, et al. 2004. Transthyretin is 
involved in depression-like behaviour and exploratory activity. 
J Neurochem, 88:1052–8.
Stauder AJ, Dickson PW, Aldred AR, et al. 1986. Synthesis of 
transthyretin (pre-albumin) mRNA in choroid plexus epithelial 
cells, localized by in situ hybridization in rat brain. J Histochem 
Cytochem, 34:949–52.
Stein TD, Anders NJ, DeCarli C, et al. 2004. Neutralization of transthyretin 
reverses the neuroprotective effects of secreted amyloid precursor 
protein (APP) in APPSW mice resulting in tau phosphorylation and 
loss of hippocampal neurons: support for the amyloid hypothesis. 
J Neurosci, 24:7707–17.
Su Y, Ryder J, Li B, et al. 2004. Lithium, a common drug for bipolar 
disorder treatment, regulates amyloid-beta precursor protein processing. 
Biochemistry, 43:6899–908.Neuropsychiatric Disease and Treatment 2006:2(4) 555
Transthyretin signal reduced by lithium
Tang YP, Haslam SZ, Conrad SE, et al. 2004. Estrogen increases brain 
expression of the mRNA encoding transthyretin, an amyloid beta 
scavenger protein. J Alzheimers Dis, 6:413–420.
Watanabe CM, Wolffram S, Ader P, et al. 2001. The in vivo neuromodulatory 
effects of the herbal medicine ginkgo biloba. Proc Natl Acad Sci U S A, 
98:6577–80.
Zachrisson O, Mathe AA, Stenfors C, et al. 1995. Region-Specific 
Effects of Chronic Lithium Administration on Neuropeptide-y and 
Somatostatin Messenger-Rna Expression in the Rat-Brain. Neurosci 
Lett, 194:89–92.